Johns Hopkins Medicine: Drug Helps Reprogram Macrophage Immune Cells, Suppress Prostate and Bladder Tumor Growth
May 22, 2024
May 22, 2024
BALTIMORE, Maryland, May 22 (TNSres) -- Johns Hopkins Medicine issued the following news release:
A novel therapy that reprograms immune cells to promote antitumor activity helped shrink hard-to-treat prostate and bladder cancers in mice, according to research from the Johns Hopkins Kimmel Cancer Center and its Bloomberg~Kimmel Institute for Cancer Immunotherapy and Johns Hopkins Drug Discovery.
The study was published online May 3 in the journal Cancer Immunology Resea . . .
A novel therapy that reprograms immune cells to promote antitumor activity helped shrink hard-to-treat prostate and bladder cancers in mice, according to research from the Johns Hopkins Kimmel Cancer Center and its Bloomberg~Kimmel Institute for Cancer Immunotherapy and Johns Hopkins Drug Discovery.
The study was published online May 3 in the journal Cancer Immunology Resea . . .